Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

145.97 -6.40 (-4.20%)
Streaming Delayed Price Updated: 12:02 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
How Is The Market Feeling About Masimo?
Via Benzinga
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
$1000 Invested In Masimo 15 Years Ago Would Be Worth This Much Today
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
Masimo Makes A Bullish Post-Earnings Move. Why One Analyst Is Cautious.
Future earnings growth could falter as Masimo makes steep cost reductions. 
Via Investor's Business Daily
Earnings Scheduled For February 25, 2025
Via Benzinga
Price Over Earnings Overview: Masimo
Via Benzinga
Masimo (MASI): Buy, Sell, or Hold Post Q4 Earnings?
What a fantastic six months it’s been for Masimo. Shares of the company have skyrocketed 45.8%, hitting $167.70. This was partly due to its solid quarterly results, and the run-up might have investors... 
Via StockStory
3 Small-Cap Stocks in Hot Water
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Xpeng, Li Auto And Nutanix Are Among Top 12 Large-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?
These large-cap stocks were top performers last week. Heico, Xpeng, Li Auto, Lineage, Erie Indemnity, Lloyds, Unum, FICO, Masimo, Smith & Nephew, AB InBev, and Nutanix all saw significant gains. 
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Via Benzinga
(MASI) - Analyzing Masimo's Short Interest
Via Benzinga
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Is Masimo (MASI) Stock Soaring Today
Shares of medical tech company Masimo (NASDAQ:MASI) jumped 11.6% in the afternoon session after the company reported impressive fourth-quarter 2024 results, which beat analysts' revenue and EPS... 
Via StockStory
Masimo Tops EPS, Revenue Expectations
Masimo impressed with a robust earnings report driven by its healthcare segment, despite challenges from non-healthcare operations. 
Via The Motley Fool
Masimo (NASDAQ:MASI) Posts Better-Than-Expected Sales In Q4
Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 9.4% year on year to $600.7 million. Its non-GAAP profit of $1.80 per share... 
Via StockStory
Deep Dive Into Masimo Stock: Analyst Perspectives (7 Ratings)
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
$1000 Invested In Masimo 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Earnings To Watch: Masimo (MASI) Reports Q4 Results Tomorrow
Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings tomorrow after the bell. Here’s what to look for. 
Via StockStory
Masimo To Rally More Than 13%? Here Are 5 Top Analyst Forecasts For Friday
Via Benzinga
What Analysts Are Saying About Masimo Stock
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
A Look Into Masimo Inc's Price Over Earnings
Via Benzinga
Expert Ratings For Masimo
Via Benzinga
Breaking Down Masimo: 5 Analysts Share Their Views
Via Benzinga
4 Analysts Assess Masimo: What You Need To Know
Via Benzinga
Buy 5 Mid-Cap Stocks Poised To Turn Into Large-Caps In 2025
The mid-cap-centric S&P 400 index has rallied 21.4% year-to-date. Within the mid-cap space, a handful of stocks have the potential to become large-caps in 2025. Here's why they may be worth... 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.